文献速递中毒与环境急症消化、代谢与肾脏急症

急诊科丁丙诺啡诱导与药物辅助治疗转诊项目的评估

Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program.
PubMed 文献 · Am J Emerg Med · 2019-07-30
一句话结论单中心回顾性分析显示,急诊科启动丁丙诺啡诱导并转诊药物辅助治疗可使49.3%的患者在30天时入组药物辅助治疗。

该单中心回顾性分析描述了2017年5月至2018年10月期间急诊科对阿片类药物使用障碍患者实施丁丙诺啡诱导并转诊至门诊药物辅助治疗的务实流程,共纳入219例患者。患者平均年龄35岁(SD 10.3),56%为男性,75%滥用静脉阿片类药物。初始COWS评分13.1(SD 5.8)提示中度戒断,平均总剂量7.7 mg(SD 3.3)。主要结局为30天时入组药物辅助治疗的比例,达49.3%;急诊停留时间中位数在研究期间下降40%。作者认为急诊科启动的丁丙诺啡诱导结合结构化务实流程能有效维持患者接受药物辅助治疗。

要点

  • 219例急诊阿片类药物使用障碍患者接受丁丙诺啡诱导,平均总剂量7.7 mg(SD 3.3),初始COWS评分13.1(SD 5.8)提示中度戒断。
  • 30天时49.3%的患者入组门诊药物辅助治疗,为主要结局指标。
  • 75%的患者滥用静脉阿片类药物,平均年龄35岁(SD 10.3),56%为男性。
  • 急诊停留时间中位数在2017年5月至2018年10月间下降40%。
  • 作者结论认为急诊科启动的丁丙诺啡诱导结合结构化务实流程能有效维持患者接受药物辅助治疗。

适用人群与场景

  • 急诊科就诊的阿片类药物使用障碍患者,接受丁丙诺啡诱导并转诊至门诊药物辅助治疗。

诊断标准与关键阈值

  • 初始COWS评分13.1(SD 5.8)提示中度戒断,据此启动丁丙诺啡诱导。

处置流程与药物剂量

  • 急诊科启动丁丙诺啡诱导,平均总剂量7.7 mg(SD 3.3),具体给药途径、频次及疗程原文未写明。
  • 诱导后转诊至门诊药物辅助治疗机构。

研究设计与关键结果

  • 单中心回顾性分析,纳入2017年5月至2018年10月期间219例急诊接受丁丙诺啡诱导并转诊的患者。
  • 主要结局:30天时入组药物辅助治疗的比例为49.3%。
  • 患者平均年龄35岁(SD 10.3),56%为男性,75%滥用静脉阿片类药物。
  • 初始COWS评分13.1(SD 5.8),平均丁丙诺啡总剂量7.7 mg(SD 3.3)。
  • 急诊停留时间中位数在2017年5月至2018年10月间下降40%。

证据类型、等级与局限

  • 证据类型:单中心回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为急诊科启动丁丙诺啡诱导结合结构化务实流程能有效维持患者接受药物辅助治疗,30天入组率为49.3%。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Emergency departments are struggling to manage the increasing number of patients seen for opioid use disorders and opioid overdose. With opioid overdose deaths rising at alarming rates, emergency physicians are beginning to induce patients with long-acting opioids such as buprenorphine and referring patients to outpatient medication-assisted treatment facilities. The objective of this study was to describe a pragmatic approach to buprenorphine induction, referral to treatment, and assess follow-up rates.

METHODS: Single center, retrospective analysis of emergency department patients undergoing buprenorphine induction and referral to outpatient medication-assisted treatment. Patients were identified by an ongoing log of induced patients, between May 2017 and October 2018. The data is analyzed using descriptive statistics, with means and associated standard deviations, medians and interquartile ranges for continuous variables, and frequencies as percentages for categorical data.

RESULTS: Overall, 219 patients were seen and induced with buprenorphine in the emergency department. Mean age was 35 years old (SD 10.3) and 56% were male. Intravenous opioids were most commonly abused at 75%. Our primary outcome of interest was the percentage of patients enrolled in MAT at 30 days, which occurred in 49.3% of our population. Patients were in moderate withdrawal based on initial COWS scores of 13.1(SD 5.8), and received mean total doses of 7.7 mg (SD 3.3). Median ED length of stay decreased by 40% between May 2017 and October 2018.

CONCLUSION: Emergency department initiated buprenorphine induction using a structured pragmatic approach is effective at maintaining patients in medication-assisted therapy.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Kaucher KA, Caruso EH, Sungar G, et al. Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program. Am J Emerg Med. 2019. PMID: 31387811. doi:10.1016/j.ajem.2019.158373

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。